{"entity":{"type":"insider","cik":"0001738061","url":"/insider/0001738061","json_url":"/insider/0001738061.json","name":"Shah Nikita","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":10,"first":"2018-08-23","last":"2026-08-13","span_basis":"filed_date"},"name_variants":[{"name":"Shah Nikita","source":"filing","n_filings":10,"first_seen":"2018-08-23","last_seen":"2026-08-13"}],"transactions":[{"id":9293696,"accession":"0001628280-26-056757","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-056757","line_url":"/filing/0001628280-26-056757#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738061","owner_name":"Shah Nikita","owner_display_name":"Shah Nikita","owner_url":"/insider/0001738061","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":146403.0,"shares_display":"146,403","price_per_share":17.51,"price_display":"17.51","price_state":"stated","total_value":2563516.53,"total_display":"2,563,516.53","total_whole":"2,563,517","shares_owned_after":253390.0,"shares_owned_after_display":"253,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-12","filed_date":"2026-08-13","scope":"insider"},{"id":4929793,"accession":"0001628280-25-052413","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-25-052413","line_url":"/filing/0001628280-25-052413#line-3","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738061","owner_name":"Shah Nikita","owner_display_name":"Shah Nikita","owner_url":"/insider/0001738061","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":131856.0,"shares_display":"131,856","price_per_share":11.92,"price_display":"11.92","price_state":"stated","total_value":1571723.52,"total_display":"1,571,723.52","total_whole":"1,571,724","shares_owned_after":146403.0,"shares_owned_after_display":"146,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-12","filed_date":"2025-11-14","scope":"insider"},{"id":4560056,"accession":"0001738061-25-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001738061-25-000004","line_url":"/filing/0001738061-25-000004#line-2","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738061","owner_name":"Shah Nikita","owner_display_name":"Shah Nikita","owner_url":"/insider/0001738061","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6340.0,"shares_display":"6,340","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":60230.0,"total_display":"60,230.00","total_whole":"60,230","shares_owned_after":146403.0,"shares_owned_after_display":"146,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-25","filed_date":"2025-08-25","scope":"insider"},{"id":4560052,"accession":"0001738061-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001738061-25-000004","line_url":"/filing/0001738061-25-000004#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738061","owner_name":"Shah Nikita","owner_display_name":"Shah Nikita","owner_url":"/insider/0001738061","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":114492.0,"shares_display":"114,492","price_per_share":9.66,"price_display":"9.66","price_state":"stated","total_value":1105992.72,"total_display":"1,105,992.72","total_whole":"1,105,993","shares_owned_after":152743.0,"shares_owned_after_display":"152,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-22","filed_date":"2025-08-25","scope":"insider"},{"id":4508001,"accession":"0001723128-25-000052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001723128-25-000052","line_url":"/filing/0001723128-25-000052#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738061","owner_name":"Shah Nikita","owner_display_name":"Shah Nikita","owner_url":"/insider/0001738061","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71694.0,"shares_display":"71,694","price_per_share":9.29,"price_display":"9.29","price_state":"stated","total_value":666037.26,"total_display":"666,037.26","total_whole":"666,037","shares_owned_after":267235.0,"shares_owned_after_display":"267,235","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-14","filed_date":"2025-08-15","scope":"insider"},{"id":5059174,"accession":"0001723128-25-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001723128-25-000050","line_url":"/filing/0001723128-25-000050#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738061","owner_name":"Shah Nikita","owner_display_name":"Shah Nikita","owner_url":"/insider/0001738061","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":9.04,"price_display":"9.04","price_state":"stated","total_value":452000.0,"total_display":"452,000.00","total_whole":"452,000","shares_owned_after":338929.0,"shares_owned_after_display":"338,929","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-13","scope":"insider"},{"id":4772903,"accession":"0001628280-25-026513","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-026513","line_url":"/filing/0001628280-25-026513#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738061","owner_name":"Shah Nikita","owner_display_name":"Shah Nikita","owner_url":"/insider/0001738061","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49140.0,"shares_display":"49,140","price_per_share":7.58,"price_display":"7.58","price_state":"stated","total_value":372481.2,"total_display":"372,481.20","total_whole":"372,481","shares_owned_after":388929.0,"shares_owned_after_display":"388,929","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-16","filed_date":"2025-05-19","scope":"insider"},{"id":2194205,"accession":"0001628280-24-037557","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-037557","line_url":"/filing/0001628280-24-037557#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738061","owner_name":"Shah Nikita","owner_display_name":"Shah Nikita","owner_url":"/insider/0001738061","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":7.75,"price_display":"7.75","price_state":"stated","total_value":775000.0,"total_display":"775,000.00","total_whole":"775,000","shares_owned_after":291666.0,"shares_owned_after_display":"291,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-16","scope":"insider"},{"id":4344948,"accession":"0001209191-21-070257","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-070257","line_url":"/filing/0001209191-21-070257#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738061","owner_name":"Shah Nikita","owner_display_name":"Shah Nikita","owner_url":"/insider/0001738061","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":3.95,"price_display":"3.95","price_state":"stated","total_value":7900.0,"total_display":"7,900.00","total_whole":"7,900","shares_owned_after":212996.0,"shares_owned_after_display":"212,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-15","filed_date":"2021-12-17","scope":"insider"},{"id":4935089,"accession":"0001209191-21-021301","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-021301","line_url":"/filing/0001209191-21-021301#line-2","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738061","owner_name":"Shah Nikita","owner_display_name":"Shah Nikita","owner_url":"/insider/0001738061","role":"Officer (Executive Vice President)","role_mark":"O","role_mark_label":"Officer (Executive Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Vice President","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36330.0,"shares_display":"36,330","price_per_share":6.8673,"price_display":"6.87","price_state":"stated","total_value":249489.009,"total_display":"249,489.01","total_whole":"249,489","shares_owned_after":211921.0,"shares_owned_after_display":"211,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":6812438,"accession":"0000899243-18-023154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-18-023154","line_url":"/filing/0000899243-18-023154#line-1","is_derivative":false,"issuer_cik":"0001723128","issuer_name":"Amneal Pharmaceuticals, Inc.","issuer_ticker":"AMRX","issuer_name_source":null,"issuer_url":"/issuer/0001723128","owner_cik":"0001738061","owner_name":"Shah Nikita","owner_display_name":"Shah Nikita","owner_url":"/insider/0001738061","role":"Officer (SVP, Chief HR Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief HR Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief HR Officer","security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":23.46,"price_display":"23.46","price_state":"stated","total_value":1173000.0,"total_display":"1,173,000.00","total_whole":"1,173,000","shares_owned_after":166036.0,"shares_owned_after_display":"166,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-21","filed_date":"2018-08-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001723128","name":"Amneal Pharmaceuticals, Inc.","url":"/issuer/0001723128","role":"Officer (Executive Vice President)","n_filings":10,"first_seen":"2018-08-23","last_seen":"2026-08-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001738061","retrieved_at":"2026-08-23T17:29:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}